A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312
about
A comprehensive overview of targeted therapy in metastatic renal cell carcinomaIndividualising treatment choices in a crowded treatment algorithmTherapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysisPhase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma.Therapeutic effects and associated adverse events of first-line treatments of advanced renal cell carcinoma (RCC): a meta-analysis.Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy.
P2860
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@ast
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@en
type
label
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@ast
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@en
prefLabel
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@ast
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@en
P2093
P2860
P1476
A phase ii study of gemcitabin ...... est Oncology Group Study S0312
@en
P2093
David E Crawford
Joseph I Clark
Marianne K Lange
Michael Hussey
Peter J Van Veldhuizen
Philip C Mack
Primo N Lara
Regina Gandour-Edwards
P2860
P304
P356
10.1097/COC.0B013E3181925176
P577
2009-10-01T00:00:00Z